SETD2 and breast carcinoma: Sarakbi et al. (Al Sarakbi et al., 2009) analyzed the expression of SETD2 mRNA in a long-term follow-up cohort of breast cancer patients and found that SETD2 expression levels were significantly reduced in samples from patients who developed metastasis, local recurrence, or died of BC.